Myasthenia Gravis Trial, Not Yet Recruiting NCT07125105 Sponsor: Universite du Littoral Cote d'Opale Condition: Myasthenia Gravis
Back to Myasthenia Gravis

Myasthenia Gravis Trial, Not Yet Recruiting

NCT07125105
Not Yet Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with myasthenia gravis (in any form) by a neurologist.
  • You are being cared for at Lille University Hospital or one of its partner services, or at Amiens University Hospital.
  • Your medical team has confirmed you have no major reasons why adapted physical activity or art therapy would be unsafe for you.
  • You are able to attend all 10 sessions of each part of the programme (a physical activity programme and a combined physical activity plus art therapy programme).
  • You are willing and able to give your signed agreement to take part after being fully informed about the study.

Who may not be able to join:

  • You have serious other health conditions that would make it difficult to take part in adapted physical activity or art therapy.
  • You have significant memory or thinking difficulties, or severe mental health conditions, that would prevent you from understanding or taking part.
  • Your myasthenia gravis treatment has changed recently or is not yet stable, or your condition is not well controlled at the moment.
  • You are physically unable to take part in adapted physical activity or art therapy, even if adjustments are made.
  • You are unable to complete the full programme, for example because you are moving away or will be absent for a long period.
  • You are unable or unwilling to give your signed agreement to take part (for example, if you are under legal guardianship without the required authorisation).
  • You cannot travel to where the sessions take place, and no alternative such as remote or home-based sessions is available.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alessandro Porrovecchio, PhD, Université du Littoral Cote d'Opale

Phone: 0033647120423

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Universite du Littoral Cote d'Opale
Registry
ClinicalTrials.gov
Start date
1 November 2025
Est. completion
30 April 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Change in Quality of Life (MG-QOL15)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov